{"id":11495,"date":"2025-07-26T16:23:36","date_gmt":"2025-07-26T14:23:36","guid":{"rendered":"https:\/\/valintermed.com\/?p=11495"},"modified":"2025-07-26T16:23:36","modified_gmt":"2025-07-26T14:23:36","slug":"geterozigotnaya-semeynaya-giperholesterinemiya-hefh","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/geterozigotnaya-semeynaya-hyperholesterinemia-hefh\/","title":{"rendered":"Heterozygous familial hypercholesterolemia (HeFH)"},"content":{"rendered":"
<\/div>\n

Heterozygous familial hypercholesterolemia (HeFH) is a hereditary disease characterized by significantly elevated levels of low-density lipoproteins (LDL) in the blood. This condition is the result of hereditary dysfunction of genes responsible for cholesterol metabolism, which leads to the accumulation of cholesterol in the body. It should be noted that HeFH leads to the early development of atherosclerosis and cardiovascular diseases, which is of significant clinical significance. Constant and average high levels of LDL cholesterol lead to the formation of atherosclerotic plaques, a high probability of heart attacks and strokes, which makes prevention and early diagnosis of the disease an integral part of medical practice.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n